After several high-profile failures, including BMS’ $1.5B breakup with Agenus, anti-TIGIT therapies are generating cautious ...

Cancer research or cardiovascular drugs may claim the Nobel Prize in Medicine, set to be announced Monday. With global crises ...

Cancer research or drugs treating cardiovascular illnesses could win a Nobel Prize on Monday when a week of laureate ...

TiumBio is dedicated to the discovery and development of new treatments for rare and incurable diseases ... Ministry of Food ...

Prolactin is an important hormone in reproduction, pregnancy and childbirth. But could it also play a role in the development ...

Ashley Hansen has served as the couple’s global communications chief for two years during a particularly tumultuous period ...

Summit Therapeutics Inc. may have a potential successor to Merck's Keytruda with strong clinical data from China, but awaits ...

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to announce a new partnership with AstraZeneca, a ...

The School of Dentistry at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) earned the first National Institutes of Health grant under its new Center for Pain ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...